Clinical Trial Update: Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immunogenicity and safety of GSK's Meningococcal ABCWY vaccine versus Meningococcal B vaccine in adolescents (completed; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections

Drugs mentioned

• Meningococcal ABCWY vaccine
• Meningococcal B vaccine (Meningococcal B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 2 | Status: COMPLETED | Results posted: 2017-07-21